SAB Biotherapeutics (SABS) Misses Q2 EPS by 79c
Get Alerts SABS Hot Sheet
Join SI Premium – FREE
SAB Biotherapeutics (NASDAQ: SABS) reported Q2 EPS of ($0.79).
For earnings history and earnings-related data on SAB Biotherapeutics (SABS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Pan American Silver (PAAS) Misses Q2 EPS by 19c
- Lulu’s Fashion Lounge Holdings (LVLU) Misses Q2 EPS by 37c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share